Valuation check: 1295.TWO's profit margin is 14.11%, above the Healthcare sector average of 9.48%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Synbio Tech's profit margin stands at 14.11% as of June 2026. That compares with 16.98% in the prior-year period — down 16.9% year over year. That is above the Healthcare sector average of 9.48%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Synbio Tech reported 14.11% in profit margin versus 16.98% a year earlier — a 16.9% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.
Synbio Tech sits higher the Healthcare benchmark (9.48%) with a profit margin of 14.11%. That is roughly 48.9% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A profit margin of 14.11% for Synbio Tech means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how Synbio Tech's profit margin evolved across reporting periods, while the comparison chart places 1295.TWO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.